Other Headlines

The medical community pays tribute to a dedicated crew.
Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.
GI monitoring device promises to speed the evaluation and treatment of GI motility disorders.
A novel microfluidic drug delivery system makes it possible to reach parts of the body poorly served by oral and injectable medications.
The "germ theory" of schizophrenia got a mild boost this week as scientists discover that recently afflicted schizophrenics show higher levels of inflammatory proteins in the brain.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More Industry Headlines

House Passes Medicare Physician Payment Reform Act Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.

Aural Trumps Oral for Ear Treatment A novel microfluidic drug delivery system makes it possible to reach parts of the body poorly served by oral and injectable medications.

Scientists Find Unusual Immune System Activity in Brains of Schizophrenics The "germ theory" of schizophrenia got a mild boost this week as scientists discover that recently afflicted schizophrenics show higher levels of inflammatory proteins in the brain.

Clinical PET-MRI Moves Closer to Reality Thanks to a European grant for the HyperIMAGE project, a consortium of scientists across Europe have worked with Philips to develop a proof-of-concept, pre-clinical combined MR-PET scanner that could one day lead to improved radiation therapy and cardiology treatments.

Senate Health Care Reform Bill Unveiled Legislation may go to cloture vote this weekend. Read the details.

RSNA 2009 Preview This year's RSNA should provide a very interesting look at the effects of the economy on the major OEMs. As always, vendors are whipping up the hoopla, and inside this story are great previews of what's being debuted. But DOTmed reporters will also be there to get the real buzz. Look for video interviews in our Online News direct from the show.

Interview With Fred Robertson, President & CEO of TomoTherapy TomoTherapy president and CEO Fred Robertson talks with DOTmed about his perspective on ASTRO's 2009 annual meeting, changes in the radiation oncology industry and two important TomoTherapy product launches that occurred at the show. Watch the HD video.

Pen-Sized Microscope Aims for Precise Brain Surgeries A confocal microscope picking up brain-safe fluorescent dyes could result in more accurate and streamlined surgeries to remove tumors from the brain.

Health Care Reform Round-Up: CBO Pegs Senate Bill at $849 Billion The numbers are in on the Senate's version of reform. Also read about the wide-ranging impact that the legislation would have.

U.S. Preventive Services Task Force Has Stunning New Guidelines on Mammography Agency recommends no routine screening for women 40-49, no self-examination. Read the details.

The latest quality
measures are in

Health Care Quality Plateaus for the First Time in a Decade

by Brendon Nafziger, Writer
Health care quality failed to improve for the first time in almost a decade in 2008, according to a report issued last week.

In the 128-page report, The State of Health Care Quality 2009, the non-profit insurance accreditor National Committee for Quality Assurance (NCQA) argues that a 12-year streak in health care gains has come to a halt. Across the dozen or so measures studied, including diabetes care, follow-ups for people on long-term medication and appropriate screenings for those at risk for colon cancer or chlamydia, fewer than half showed any improvement in the health plans covered.

The gradual decline in overuse of inappropriate treatments, such as imaging tests for low back pain and antibiotics for bronchitis, also flatlined.

Intriguingly, NCQA also found, at least among the plans studied, almost no relationship between money spent and quality of care in such measures as heart disease, hypertension, asthma and lower back pain.

And in keeping with the findings of other health care rankings, wide regional variation in quality was seen, with the South Central states, such as Louisiana, Texas and Arkansas, coming in dead last. Although NCQA acknowledges there might be demographic reasons for the difference, for example, the region is, in general, poorer than the rest of the country, the committee does not believe this accounts for the whole performance gap.

"We believe there are several factors at work," Daniel Danzig, a spokesman for NCQA, tells DOTmed News by e-mail. "First, the region does have more poverty and more incidence of conditions like diabetes and obesity. But we also believe there is insufficient focus on quality in this region and that the plans are not getting a clear and consistent message that quality matters."

"This kind of regional variation should be unacceptable," he adds.

NCQA believes between 50,000 and 115,000 lives, and about $12 billion in health care costs and lost productivity, could have been saved nationwide in 2008 alone if all insurance plans were at the level of those in the top ten percentiles.

Silver Linings and Limitations

That said, although there is certainly room for improvement, NCQA concedes that some of the health measures have plateaued at a high level. The ones showing the least progress now are those for mental illness and substance abuse, as well as some preventive screenings, including for colon cancer.

And some measures are still improving, for instance, NCQA reports that around 90 percent of Americans with asthma now have access to appropriate care, with little differences among the plans.

And it should be noted that NCQA's study only covers about the two out of five -- or 116 million -- Americans whose health plans report measures of improvement in NCQA's Health Care Effectiveness Data and Information Set (HEDIS). The most likely to report are large, commercial health plans from big companies, such as Fortune 400 firms that have performance targets to meet, according to Danzig.

"Plans that don't report tend to be either smaller plans that don't see this as a priority or large state-based plans (i.e., Blues plans) that are immune to market pressures to report (i.e. they have a large share of the market and purchasers have little sway with them)," Danzig explains.

Government-run plans are also often report shy: only about 16 percent of all Medicare plans, mostly Medicare Advantage plans, that are partly privately managed, pass on their HEDIS stats to NCQA.

In the NCQA report, Medicare and Medicaid plans lag behind fully commercial ones in quality improvement, and NCQA says the public plan quality measures have been stagnating for the last three years.

So what should be done? Among other recommendations, NCQA suggests that politicians include in the reform bills now passing through Congress some mechanism to force insurance plans to report health care measures or lose accreditation. And for Medicare and Medicaid, they would like to see some sort of pay-for-performance strategy, along with better data reporting.

To download the free report, visit: http://www.ncqa.org/tabid/836/Default.aspx

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED